What is the dosage of testosterone phenylpropionate?
250 mg of Testosterone Phenylpropionate at 250 mg/mL is 1 mL, the 100 mark on a U-100 syringe.
Every vial at a glance. Pick a cell to draw it on the syringe.
| Concentration | Draw per dose |
|---|---|
| 250 mg/mL | 250 mg/mL: 250 mg is 1 mL, the 100 mark |
Sustanon 250, the sourced product containing testosterone phenylpropionate (60 mg per 1 ml ampoule), is labelled in the UK for adults with male hypogonadism at usually one 1 ml injection per 3 weeks, adjusted to the individual patient's response; searches of DailyMed, emc, Medsafe and trial registries found no label or trial that doses the ester alone.1
Strengths and syringe marks
250 mg of Testosterone Phenylpropionate at 250 mg/mL is 1 mL, the 100 mark on a U-100 syringe.
250 mg of Testosterone Phenylpropionate at 250 mg/mL is 1 mL, the 100 mark on a U-100 syringe.
The only sourced product is Sustanon 250, a 250 mg/mL solution in oil of four esters.1 Each 1 ml ampoule holds 60 mg of testosterone phenylpropionate and 176 mg of total testosterone.1 The UK label describes it as a solution in oil and gives no water or mixing step.1 The strength table, worked line and calculator above use the mixture's 250 mg/ml, so the label's 1 ml injection is 1 ml of the four-ester mixture, 60 mg of it phenylpropionate.1 Searches of DailyMed and the web returned no label for testosterone phenylpropionate as a single ingredient.
Label dose and schedule
For adults (including the elderly), the UK label for Sustanon 250 says one injection of 1 ml per 3 weeks is usually adequate, with the dose adjusted to the response of the individual patient; its indication is testosterone replacement for male hypogonadism confirmed by clinical features and biochemical tests.1 The New Zealand data sheet, for adults including the elderly, also says one injection of 1 ml per three weeks is usually adequate, with the dose adjusted to the individual patient's response.2 Neither document gives a dose for phenylpropionate alone.
What trials of the mixtures used
Every human trial the searches found that gave phenylpropionate gave it inside a mixture of esters; none gave it alone. Two of them, by Forsdahl and colleagues (one with six participants, one with six healthy volunteers), were doping-detection studies comparing the mixture with testosterone undecanoate, not dose studies.34
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Büyükgebiz, 1995 | 200 mg intramuscularly, 4 doses at 3-week intervals (propionate, phenylpropionate, isocaproate)5 | Thirteen boys with constitutional delayed puberty5 | 2 years follow-up5 |
| NCT01454011 (Gulhane School of Medicine) | Sustanon 250 mg ampoule (four esters, 60 mg phenylpropionate) at 3-week intervals, against 50mg transdermal testosterone gel in every night; arms not randomised6 | 140 enrolled, male only: patients with congenital hypogonadotrophic hypogonadism and healthy controls6 | 6 months6 |
| Forsdahl, 2015 | One intramuscular injection of the four-ester mixture (60 mg phenylpropionate) or 1000 mg testosterone undecanoate3 | Six participants across both arms3 | 60 days of blood samples3 |
| Forsdahl, 2020 | One intramuscular injection of the four-ester mixture (60 mg phenylpropionate) or 1000 mg testosterone undecanoate4 | Six healthy volunteers across both arms4 | 60 days of urine samples4 |
Half-life against propionate
A chemistry paper by Turza and colleagues, published in 2022, not a human dose study, gives about 2.5 days for phenylpropionate and 1 day for propionate.7 It adds that the longer the ester, the longer the half-life.7 The UK label gives no half-life for phenylpropionate.1 The app's own figure is 36 hours, shorter than the 2.5 days the chemistry paper gives.7
Storage
The UK label gives a shelf life of 5 years and says to store it below 30°C, not to refrigerate or freeze it, and to keep it in the original package to protect it from light.1 The New Zealand data sheet gives 60 months, below 30 °C, not refrigerated or frozen, in the original package.2 For vials, which it lists as single use in one patient only and not currently available, it says to inject the solution immediately after withdrawing it; for ampoules it says the sterility of the contents cannot be guaranteed once resealed, so the solution is to be used immediately; it gives no separate in-use period.2
Frequently asked questions
References
- electronic medicines compendium (UK). Sustanon 250, 250mg/ml solution for injection - Summary of Product Characteristics (SmPC) - print friendly - (emc). 2026. medicines.org.uk
- Medsafe (New Zealand). SUSTANON. 2026. medsafe.govt.nz
- Drug testing and analysis (PubMed abstract). Detection of testosterone esters in blood. 2015. pubmed.ncbi.nlm.nih.gov
- Steroids (PubMed abstract). Quantification of endogenous steroid sulfates and glucuronides in human urine after intramuscular administration of testosterone esters. 2020. pubmed.ncbi.nlm.nih.gov
- Hormone research (PubMed abstract). Treatment of constitutional delayed puberty with a combination of testosterone esters. 1995. pubmed.ncbi.nlm.nih.gov
- ClinicalTrials.gov (US National Library of Medicine). NCT01454011: The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups. 2011. clinicaltrials.gov
- Materials (full text, PubMed Central). Structural Aspects and Intermolecular Energy for Some Short Testosterone Esters. 2022. pmc.ncbi.nlm.nih.gov